Practical Approaches for Managing Moderate to Severe Pediatric Atopic Dermatitis: A Pharmacist’s Review of Novel Treatments and Caregiver Counseling Pearls

This activity includes caregiver counseling video vignettes.

Program Description

For children with moderate to severe atopic dermatitis (AD), attaining control of symptoms and avoiding triggers of AD flares are important. Pediatric patients can experience significant impairments to their quality of life, mental development, self-esteem, and physical limitations affecting their ability to engage with peers. The effects of AD can also negatively impact caregivers, so pharmacist involvement in the management of pediatric patients with AD should include counseling for caregivers. Expert panelists will discuss a variety of over-the-counter creams and moisturizers, topical prescription agents, emerging biologics, and other medication classes to equip pharmacists to navigate the options for supportive care and treatment of AD. This activity will also feature counseling videos highlighting novel administration considerations of emerging therapies and the central role of pharmacists in demonstrating proper administration to patients and caregivers as well as counseling on adherence.

Target audience: Specialty pharmacists

Type of activity: Application
Release date: August 29, 2022
Expiration date: August 29, 2023

Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Discover the pathogenesis of moderate to severe pediatric atopic dermatitis (AD), the psychosocial impact of disease, and treatment challenges impacting quality of life for both patients and caregivers
• Examine updated guideline-directed pharmacologic and nonpharmacologic treatments for pediatric patients with moderate to severe AD
• Analyze efficacy and safety data, novel mechanisms of action, and routes of administration associated with recently approved and emerging agents for the treatment of moderate to severe pediatric AD
• Customize counseling pearls for patients and caregivers based on individualized treatment plans to improve adherence to new and emerging therapies among pediatric patients with AD